Catalysts
PRODUCTS
-
BioBLU Single-Use Bioreactors combine the advantages of single-use technology with the trusted performance of stirred-tank design. Different variants are suitable for cell culture and microbial fermentation in R&D and clinical and commercial manufacturing. BioBLU Single-Use Bioreactors are compatible Eppendorf bioprocess controllers.
-
The MEQ6-45CSP1 is a passive MMIC equalizer CSP ideal for compensating for low pass filtering effects in RF/microwave and high speed digital systems.
-
When applied to plant influents, hydrogen peroxide destroys dissolved and/or total sulfide that otherwise scavenges Fe3+ added for CEPT and/or chemical phosphorus removal from wastewater. The foundational aspect of this PRI-TECH application (called PRI-CEPT) is that one lb of total sulfide theoretically consumes 3.5 lbs Fe3+ and thus represents an additional cost of $2 – 3 per lb influent sulfide.
-
In today’s complex clinical research landscape, sponsors and CROs face numerous challenges that can impact study timelines, costs, and data quality. The iMednet platform offers innovative solutions to address these critical issues.
-
Building on the capabilities of the NP-RD10A benchtop tablet press (discussed in our previous article on USP <1062>), our services are further enhanced by the integration of the Presster™ compaction emulator. This state-of-the-art tool is designed to replicate the compaction dynamics of production tablet presses in a laboratory setting. It allows for tangible fine-tuning of the compression cycle, providing an accurate depiction of how a tablting formulation will behave under commercial manufacturing conditions. Using the Presster, Natoli Scientific can simulate full-scale production, permitting us to forecast problems before they escalate to costly production delays. Our experts can optimize the tablet design for our clients, ensuring a smooth transition from laboratory to production while adhering to the rigorous standards set by the industry including the current USP <1062> chapter.
WHITE PAPERS AND CASE STUDIES
-
Rapid Assessment Of Fab-VHH Expression
Find out how a 10-day expression screening program rapidly identified optimal gene orientation for a bi-specific antibody fragment fusion, achieving up to 570 µg/mL soluble, active product.
-
CRO Takes Trial Build Times From Weeks To Days
Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.
-
Accelerate European Market Access With MAA Submission
Discover how ensuring preparedness for Marketing Authorization Application (MAA) approval can streamline your application process and subsequent follow-up.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Leak Detection Program For Roswell, New Mexico
Harnessing satellite intelligence allows utilities to pinpoint hidden underground leaks with precision. By focusing field crews on high-probability clusters, municipalities can drastically reduce water loss, optimize repair budgets, and prioritize critical infrastructure replacement projects.
-
Illumina Fortifies Supplier Relationship With Digitalization
Illumina improved its quality management by adopting digitalization, enhancing supplier collaboration and efficiency in monitoring, while transitioning from rigid manual processes to a streamlined, integrated system.
-
Global Vaccine Trials Case Study
Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.
-
Successful EU MAA Submission Enabled By U.S.–EU Regulatory Collaboration
Facing EU MAA complexity? Learn how one oncology sponsor met a fixed EMA deadline through global regulatory coordination, rapid dossier adaptation, and real-time submission execution.
-
Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies
To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.
-
Large-Scale Exosome Production Stirred-Tank Bioreactors
Discover how engineered exosomes, displaying tumor-homing peptides, offer a promising tool for targeted cytotoxic drug delivery, produced efficiently with a bioreactor for critical research.
-
Emory University Uses Oracle Cloud To Help Fight Parkinson's Disease
Discover how researchers at Emory University were able to overcome challenges with computational resources and enable faster compute speeds and HIPAA compliance.
-
What The Hidden Springs Pilot Case Study Reveals About Cutting-Edge Water Treatment
A seven-month pilot study shows how ozone treatment reduced hydrogen sulfide and TOC at the Hidden Springs Water Treatment Facility, improving water quality and validating a scalable alternative.
NEWS
-
ANDRITZ To Supply New Generators For Bridge River 1 Hydropower Plant In Canada3/11/2025
International technology group ANDRITZ has received an order from the Canadian utility BC Hydro to supply four 60 MVA generators for the Bridge River 1 hydropower plant in British Columbia.
-
Quicklly Changes The Online Indian Grocery Landscape By Partnering With Major Online Platforms5/27/2025
Quicklly, the nation's most comprehensive South Asian marketplace, is transforming the way Indian grocery stores connect with their customers.
-
Pasternack's Newest Gain Horn Antennas Include Cage-Style Mounts And Coaxial Adapters1/20/2025
Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave and millimeter-wave products, has launched its new in-house pre-built standard gain horn assemblies featuring coax adapters and antenna mounts.
-
KRYTAR Celebrating 50-year Anniversary Serving the RF/Microwave Community5/15/2025
You’re Invited to Stop by KRYTAR Booth 1635 during IMS2025
-
Nordic Bluetooth LE Solar-Powered Asset Tracker Can Operate For Up To Three Weeks In Total Darkness1/20/2025
French embedded systems developer InVirtus Technologies has launched its ‘EosFlex’ and ‘EosFlexMini’ asset tracking devices for ultra-low power locationing using Bluetooth LE wireless connectivity.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.